PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AVITA Medical, Inc. (RCEL)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US05380C1027

CUSIP

05380C102

Sector

Healthcare

IPO Date

Oct 1, 2019

Highlights

Market Cap

$328.51M

EPS (TTM)

-$2.23

Total Revenue (TTM)

$60.04M

Gross Profit (TTM)

$51.43M

Year Range

$7.51 - $18.93

Target Price

$16.35

Short %

4.49%

Short Ratio

10.24

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
RCEL vs. ORI RCEL vs. O
Popular comparisons:
RCEL vs. ORI RCEL vs. O

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in AVITA Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
39.28%
7.29%
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Returns By Period

AVITA Medical, Inc. had a return of -15.74% year-to-date (YTD) and -9.90% in the last 12 months.


RCEL

YTD

-15.74%

1M

-7.00%

6M

44.14%

1Y

-9.90%

5Y*

-23.70%

10Y*

N/A

^GSPC (Benchmark)

YTD

23.11%

1M

-0.36%

6M

7.02%

1Y

23.15%

5Y*

12.80%

10Y*

11.01%

Monthly Returns

The table below presents the monthly returns of RCEL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202422.16%8.17%-11.58%-47.60%14.40%-17.59%23.74%-4.49%14.53%-5.78%26.93%-15.74%
202341.52%43.58%4.18%11.10%-26.42%48.95%19.05%-19.51%-10.37%-36.28%14.50%28.71%107.88%
2022-19.28%-4.86%-7.83%-28.07%-6.56%-16.67%18.53%9.77%-14.72%-7.21%35.99%-0.75%-44.91%
202132.88%-11.95%-8.83%4.14%-12.50%13.62%-9.70%9.07%-12.32%-7.05%-16.45%-12.94%-35.52%
2020-6.04%-10.06%-19.38%-2.26%6.27%-5.16%-28.72%17.73%-1.83%-18.60%5.57%-14.06%-59.16%
20198.96%3.75%6.06%19.89%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RCEL is 43, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RCEL is 4343
Overall Rank
The Sharpe Ratio Rank of RCEL is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of RCEL is 4242
Sortino Ratio Rank
The Omega Ratio Rank of RCEL is 4242
Omega Ratio Rank
The Calmar Ratio Rank of RCEL is 4343
Calmar Ratio Rank
The Martin Ratio Rank of RCEL is 4545
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for AVITA Medical, Inc. (RCEL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for RCEL, currently valued at -0.10, compared to the broader market-4.00-2.000.002.00-0.101.90
The chart of Sortino ratio for RCEL, currently valued at 0.31, compared to the broader market-4.00-2.000.002.004.000.312.54
The chart of Omega ratio for RCEL, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.35
The chart of Calmar ratio for RCEL, currently valued at -0.08, compared to the broader market0.002.004.006.00-0.082.81
The chart of Martin ratio for RCEL, currently valued at -0.17, compared to the broader market0.0010.0020.00-0.1712.39
RCEL
^GSPC

The current AVITA Medical, Inc. Sharpe ratio is -0.10. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of AVITA Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.10
1.90
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


AVITA Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-79.06%
-3.58%
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the AVITA Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the AVITA Medical, Inc. was 91.79%, occurring on Oct 14, 2022. The portfolio has not yet recovered.

The current AVITA Medical, Inc. drawdown is 79.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.79%Feb 20, 2020670Oct 14, 2022
-26.8%Nov 13, 20197Nov 21, 201935Jan 14, 202042
-17.63%Jan 17, 202010Jan 31, 20207Feb 11, 202017
-15.26%Oct 24, 20195Oct 30, 20196Nov 7, 201911
-6.19%Oct 2, 20191Oct 2, 20197Oct 11, 20198

Volatility

Volatility Chart

The current AVITA Medical, Inc. volatility is 15.59%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember
15.59%
3.64%
RCEL (AVITA Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of AVITA Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for AVITA Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab